Table 1.
Clinical and Demographic Characteristics of Subjects With Type 2 Diabetes Who Had at Least 2 ACR Measurements Within 6 Years
| Baseline Characteristic | |
|---|---|
| No. of patients | 983 |
| Men | 331 |
| Women | 652 |
| Age (y) | 46.2 ± 13.5 |
| Duration of diabetes (y) | 9.1 ± 7.4 |
| Mean arterial pressure (mm Hg) | 93.4 ± 13.1 |
| Hemoglobin A1c (%) | 8.5 ± 2.5 |
| ACR−1 (mg/g) | 20.6 (11.0–67.4) |
| ACR0 (mg/g) | 26.5 (12.7–120.9) |
| Time between ACR−1 and ACR0 (y) | 2.4 (2.0–3.3) |
| Body mass index (kg/m2) | 34.6 ± 8.2 |
| Serum cholesterol (mg/dL) | 182.9 ± 40.5 |
| Fasting plasma glucose (mg/dL) | 196.4 ± 78.2 |
| Serum creatinine (mg/dL) | 0.8 ± 0.7 |
| Estimated glomerular filtration rate(mL/min/1.73 m2) | 115.9 ± 35.1 |
| Antihypertensive medicines (%) | 22 |
Note: Values expressed as mean ± SD, median (25th to 75th percentiles), number of patients, or percent. Fasting plasma glucose concentration was missing in 11 subjects, and body mass index was missing in 2 subjects. To convert serum creatinine in mg/dL to μmol/L, multiply by 88.4; serum cholesterol in mg/dL to mmol/L, multiply by 0.02586; plasma glucose in mg/dL to mmol/L, multiply by 0.05551; glomerular filtration rate in mL/min to mL/s, multiply by 0.01667.
Abbreviations: ACR0, second ACR measurement; ACR−1, first ACR measurement; ACR, albumin-creatinine ratio.